EAVI2020 EAVI2020 on Twitter EAVI2020 on LinkedIn

EAVI2020 presented at the 2016 NAC ANNUAL MEETING, California, 18th February 2016

graphic illustration of a viral cell with red blood cells

The Neutralizing Antibody Consortium (NAC) held its Annual meeting in La Jolla, California, on the 16th to 18th February 2016.

The NAC was launched by EAVI2020’s project partner IAVI in 2002 to solve a fundamental problem in HIV vaccine development: the elicitation of antibodies that can neutralize a broad range of HIV variants.

EAVI2020 – an accelerated pipeline to Experimental medicine trials

Prof Robin Shattock, Chair in Mucosal Infection and Immunity at Imperial College and coordinator of EAVI2020, presented the EAVI2020 project during the annual meeting, which aimed to draw together and coordinate the efforts of scientists working on different aspects of HIV vaccine development.

Prof Shattock also took the opportunity to foster collaboration and synergy of effort with EAVI2020’s collaborators at Scripps who, along with IAVI, have opened the IAVI Neutralizing Antibody Center, which is also the headquarters for the NAC.

More information

The IAVI website has more information on the NEUTRALIZING ANTIBODY CONSORTIUM (NAC) and more information on IAVI’s Neutralizing Antibody Center.

For more information about EAVI2020, please contact us.

Latest Posts

graphic illustration of red blood cells around a HIV virus cell
The Quest for an HIV…
June 24, 2022
World AIDS Vaccine Day…
May 18, 2022
Professor Gabriella Scarlatti hosting a panel, with Professor Robin Shattock and Dr Hans Langedijk in view
What’s next for…
April 28, 2022